249 related articles for article (PubMed ID: 18400455)
21. The endocannabinoid system as a target for the treatment of cannabis dependence.
Clapper JR; Mangieri RA; Piomelli D
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):235-43. PubMed ID: 18691603
[TBL] [Abstract][Full Text] [Related]
22. The endocannabinoid system in the cancer therapy: an overview.
Grimaldi C; Capasso A
Curr Med Chem; 2011; 18(11):1575-83. PubMed ID: 21428888
[TBL] [Abstract][Full Text] [Related]
23. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid system in ageing: a new target for drug development.
Paradisi A; Oddi S; Maccarrone M
Curr Drug Targets; 2006 Nov; 7(11):1539-52. PubMed ID: 17100593
[TBL] [Abstract][Full Text] [Related]
25. Endocannabinoids in neuroimmunology and stress.
Carrier EJ; Patel S; Hillard CJ
Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):657-65. PubMed ID: 16375683
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoid mechanisms of pain modulation.
Hohmann AG; Suplita RL
AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
[TBL] [Abstract][Full Text] [Related]
27. Endocannabinoids and neurodegenerative diseases.
Micale V; Mazzola C; Drago F
Pharmacol Res; 2007 Nov; 56(5):382-92. PubMed ID: 17950616
[TBL] [Abstract][Full Text] [Related]
28. The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease.
Bedse G; Romano A; Lavecchia AM; Cassano T; Gaetani S
J Alzheimers Dis; 2015; 43(4):1115-36. PubMed ID: 25147120
[TBL] [Abstract][Full Text] [Related]
29. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptors and endocannabinoids: evidence for new players.
Mackie K; Stella N
AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
[TBL] [Abstract][Full Text] [Related]
32. [The endocannabinoid system: a new paradigm in the metabolic syndrome treatment].
de Godoy-Matos AF; Guedes EP; de Souza LL; Valério CM
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):390-9. PubMed ID: 16767305
[TBL] [Abstract][Full Text] [Related]
33. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Fernández-Ruiz J; Romero J; Ramos JA
Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
Di Marzo V
Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis.
Rossi S; Furlan R; De Chiara V; Muzio L; Musella A; Motta C; Studer V; Cavasinni F; Bernardi G; Martino G; Cravatt BF; Lutz B; Maccarrone M; Centonze D
Brain Behav Immun; 2011 Aug; 25(6):1242-8. PubMed ID: 21473912
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
37. Endocannabinoids and their role in fatty liver disease.
Mallat A; Lotersztajn S
Dig Dis; 2010; 28(1):261-6. PubMed ID: 20460921
[TBL] [Abstract][Full Text] [Related]
38. [The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans].
Komorowski J; Stepień H
Postepy Hig Med Dosw (Online); 2007; 61():99-105. PubMed ID: 17369778
[TBL] [Abstract][Full Text] [Related]
39. The endocannabinoid system and the treatment of mood and anxiety disorders.
Hill MN; Gorzalka BB
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):451-8. PubMed ID: 19839936
[TBL] [Abstract][Full Text] [Related]
40. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
